CSE: BUX | OTCQB: BMKDF
An amazing show of public support for UBC disease researcher Dr. Horciao Bach, who has started his COVID-19 antibody development project. Dr. Horacio Bach is one of BioMark’s scientific advisors and is expert on antibody engineering. He has received a major grant from CIHR for COVID- 19 antibody development.
More information can be found at @DiseasesUbc
BioMark Diagnostics Inc. announces its upcoming participation in two premier Canadian life sciences events: MSACL 2026 and BIOHorizon 2026 . The company will present advances in its metabolomics-based liquid biopsy
BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum BioMark Comprehensive Metabolomics Assay Selected asTop Canadian Innovation for the CTS Beaver Den Innovation Award VANCOUVER,
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors Expanding U.S. market access with an experienced technology investor and AI-driven growth strategist VANCOUVER, BRITISH COLUMBIA – (December
